VS101 Insert Dose C — clinical trials using this drug

Public-registry trials using VS101 Insert Dose C that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.

Trial	Sponsor	Condition	Phase	Sites
A Phase 1/2 Multicenter, Randomized, Study to Evaluate the Safety and Efficacy of VS101 Subconjunctival Latanoprost Insert in Subjects With Open-Angle Glaucoma or Ocular Hypertension	ViSci Ltd.	Open Angle Glaucoma	PHASE1 / PHASE2	1

Registry history

First registered study	May 2014 — NCT02129673 (ViSci Ltd.)
Registered studies matching this name	1 all-time · 0 currently recruiting

Source: ClinicalTrials.gov, the public trial registry.

Free site-risk snapshot for any of these trials

Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Related drugs & trials

Trialed alongside

Other Open Angle Glaucoma drugs

← Eichor home · All tracked trials · Open Angle Glaucoma studies · Weekly briefs

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →